Sadeem Ahmad, Ph.D., Postdoctoral FellowBoston Children’s Hospital

Some of the most potentially effective and elegant ways to fight cancer can be found in our own natural systems, which is what I seek to exploit through my research.
Area of Research: All Cancers

Our cells have specialized immune receptors to recognize and respond to viral infections. One of these, MDA5 (melanoma differentiation associated gene 5), recognizes viral RNA and is also important for anti-tumor immune responses. However, improper MDA5 activation is associated with autoimmune diseases such as lupus and Aicardi-Goutieres syndrome (AGS). To define MDA5 activity, Dr. Ahmad is investigating which RNAs turn it on and which don’t. To do so, he’s developed a novel way to test how well different RNAs bind to and stimulate MDA5. By identifying the RNAs responsible for autoimmunity and those that could enhance anti-cancer immune responses, approaches could then be developed to turn MDA5 off (to limit autoimmunity) and on (to promote anti-cancer responses) in different contexts to help multiple patient populations.

Projects and Grants

Non-canonical activation of the innate immune receptor MDA5 in immune disorder and cancer therapy

Boston Children’s Hospital | All Cancers, Childhood Cancer | 2017 | Sun Hur, Ph.D.

Let's spread the word about Immunotherapy! Click to share this page with your community.

*Immunotherapy results may vary from patient to patient.